Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach

Integrative Cancer Therapies
Michail NikolaouMaria Tolia

Abstract

Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist's point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate.

References

Jan 1, 1990·Advances in Experimental Medicine and Biology·H C Nauts, J R McLaren
Jul 16, 1987·Nature·J F BrunetP Golstein
Jan 1, 1970·Progress in Experimental Tumor Research·F M Burnet
Jan 1, 1994·Pharmacology & Therapeutics·B Wiemann, C O Starnes
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Feb 24, 2000·The Journal of Experimental Medicine·M J SmythD I Godfrey
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Mar 5, 2003·Medical Hypotheses·Mark A Brudnak, Stephanie G Hoener
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jul 23, 2004·The New England Journal of Medicine·Deborah Schrag
Mar 28, 2007·Immunology·Ryungsa KimKazuaki Tanabe
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Jan 30, 2009·The New England Journal of Medicine·Peter B Bach
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Oct 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·K Robin YabroffAngela Mariotto
Aug 21, 2013·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Dora LiuHarold Kim
Sep 6, 2014·Chinese Journal of Cancer·Gaurav Goel, Weijing Sun
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Daniel M GeynismanYa-Chen Tina Shih
Dec 30, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Le MinUrsula B Kaiser
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Douglas B JohnsonJeffrey A Sosman
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Aug 25, 2015·Aging·Le MinUrsula B Kaiser
Dec 3, 2015·Translational Lung Cancer Research·Jeryl Villadolid, Asim Amin
Dec 31, 2015·Ecancermedicalscience·Felipe Ades, Nise Yamaguchi
Mar 10, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiJedd D Wolchok
Oct 9, 2016·The New England Journal of Medicine·Alexander M M EggermontAlessandro Testori
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Dec 27, 2016·Frontiers in Immunology·Kankana BardhanVassiliki A Boussiotis
Feb 27, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meredith K ChukRichard Pazdur
Apr 21, 2017·Expert Review of Anticancer Therapy·E SkafidaA Digklia
Oct 7, 2017·JAMA Oncology·Daniel A Goldstein

❮ Previous
Next ❯

Citations

Oct 13, 2020·Frontiers in Immunology·Nor Adzimah Johdi, Nur Fazilah Sukor

❮ Previous
Next ❯

Software Mentioned

irRECIST

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
© 2022 Meta ULC. All rights reserved